by 
The internal nasal dilators market has seen tremendous growth in recent years mainly due to the rising prevalence of snoring and nasal congestion issues amongst individuals. Internal nasal dilators are small, plastic devices that are inserted into the nostrils and help to provide relief from snoring and nasal congestion by opening up the nasal airway. They work by gently pulling open the nasal passage to allow more air to flow through during breathing. Some key advantages of these nasal dilators include convenience of use, being drug-free, and effectiveness in treating a range of nasal issues like snoring and nasal blockages.
The global internal nasal dilators market is estimated to be valued at US$ 10.11 billion in 2024 and is expected to exhibit a CAGR of 11% over the forecast period of 2023 to 2030.
Key Takeaways
Key players operating in the internal nasal dilators market are Becton, Dickinson and Company, Gerresheimer AG, Sharps Technology, Inc., Cardinal Health, lomMedical, MHC Medical Products, LLC, Sol-Millennium, UltiMed Inc., VOGT MEDICAL, Retractable Technologies, Inc., Dmcmedical, BIOCORP, Hindustan Syringes & Medical Devices Ltd, Owen Mumford Ltd., B. Braun SE, Terumo Europe NV, Smiths Group plc, Merit Medical Systems, Nipro Corporation, GPC Medical Ltd., AdvaCare Pharma.
The market provides various growth opportunities such as technological advancements leading to development of more effective nasal dilator designs and rising awareness about sleep apnea and respiratory issues.
The global expansion of the internal nasal dilators market is supported by growing geriatric population prone to nasal problems, rising disposable incomes in developing economies enabling better access to healthcare, and increasing partnerships between key players and regional medical device distributors.
Market Drivers
The key drivers contributing to the growth of the internal nasal dilators market include growing prevalence of snoring affecting quality of life, increasing respiratory problem burden globally mainly due to rising pollution and lifestyle changes, and rising awareness about availability of convenient drug-free treatment options for nasal issues through internal nasal dilators. Further, the related symptoms of nasal blockages and difficulty in breathing are becoming more common owing to increased allergies and chronic diseases. This is anticipated to propel the demand for internal nasal dilators for long-term management of such nasal issues.
PEST Analysis
Political: Regulations regarding use of devices for internal nasal dilators may affect the market. Certification requirements need to be met by manufacturers.
Economic: Overall economic growth, disposable incomes of population, and spending on healthcare affect demand for internal nasal dilators.
Social: Growing awareness among people regarding breathing difficulties can drive demand. Preferences for non-invasive treatment methods are trends that help the market.
Technological: Developments that make devices more precise, user-friendly and effective at expanding nasal cavities boost the market. Integration of sensors for monitoring parameters aids clinicians.
Geographical concentration of market in terms of value
The market for internal nasal dilators is concentrated in North America and Europe due to high healthcare expenditures and awareness in countries like the US, Germany, France and the UK. The large patient population and improving access to insurance-backed medications in the US contribute significantly to market revenues.
Fastest growing region
Asia Pacific region is poised to showcase fastest growth in the internal nasal dilators market during the forecast period. Factors such as rising medical tourism, growing per capita incomes and expanding middle class are expected to drive stronger demand across nations like China, India and Japan. Initiatives aimed at strengthening healthcare infrastructure also support market expansion here.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
